Amphix Bio Secures $12.5 Million Seed Funding to Boost Peptide Drug Development Amphix Bio has successfully raised $12.5 million in seed funding aimed at developing peptide-based therapies for neurological conditions.

Amphix Bio Secures $12.5 Million Seed Funding to Boost Peptide Drug Development #USA #Chicago #regenerative_medicine #Amphix_Bio #Peptide_Therapy

Amphix Bio Achieves FDA Orphan Drug Status for Revolutionary Spinal Cord Injury Treatment Amphix Bio has received FDA Orphan Drug Designation for its innovative therapeutic targeting acute spinal cord injuries, offering hope to many.

Amphix Bio Achieves FDA Orphan Drug Status for Revolutionary Spinal Cord Injury Treatment #United_States #Chicago #Orphan_Drug #Amphix_Bio #AMFX-200